Mokari Atabak
Corcept Therapeutics Incorporated · Chief Financial Officer
Mokari Atabak is listed in filings as Chief Financial Officer at Corcept Therapeutics Incorporated. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Corcept Therapeutics Incorporated (CORT). The current snapshot covers public activity from Sep 4, 2025 to Jun 3, 2026. Reported amounts are shown as $14.3K to $14.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||